Task Force 9: Clinical Considerations for the Care of Athletes with Cardiac Channelopathies

Cardiac channelopathies, including long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, and short QT syndrome, are heterogeneous conditions, which can lead to varying risks in athletes depending on their symptoms, disease severity, genotype, and therapies initiated. Historically, athletes with these conditions were excluded from participation with blanket restrictions, despite an absence of data. More recently, a number of studies have provided more scientific evidence to guide decision making and have been incorporated into these guidelines for athletes with cardiac channelopathies. Many athletes with these conditions may be supported in their decision to return to play as part of a shared decision-making model when they have been assessed, risk stratified, and appropriately treated by a specialist with expertise in these conditions.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2026-11-13
DOI
https://doi.org/10.1249/mss.0000000000004097
Primary Topic
Cardiovascular Effects of Exercise
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Task Force 9: Clinical Considerations for the Care of Athletes with Cardiac Channelopathies

Eugene H. Chung, Jonathan H. Kim, Michael John Ackerman, Aaron Leigh Baggish et al.
1 links
Medicine & Science in Sports & Exercise
Cardiovascular Effects of Exercise
article

Task Force 9: Clinical Considerations for the Care of Athletes with Cardiac Channelopathies

Eugene H. Chung, Jonathan H. Kim, Michael John Ackerman, Aaron Leigh Baggish, Mark S. Link, Benjamin D. Levine, Belinda Gray, SUSAN ETHERIDGE
article en

Abstract

Cardiac channelopathies, including long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, and short QT syndrome, are heterogeneous conditions, which can lead to varying risks in athletes depending on their symptoms, disease severity, genotype, and therapies initiated. Historically, athletes with these conditions were excluded from participation with blanket restrictions, despite an absence of data. More recently, a number of studies have provided more scientific evidence to guide decision making and have been incorporated into these guidelines for athletes with cardiac channelopathies. Many athletes with these conditions may be supported in their decision to return to play as part of a shared decision-making model when they have been assessed, risk stratified, and appropriately treated by a specialist with expertise in these conditions.

Medicine & Science in Sports & ExerciseVol. 58(12)
The University of Sydney (AU), Mayo Clinic (US), Harvard University (US), Emory University (US), Royal Prince Alfred Hospital (AU), Texas Health Dallas (US), Centre Hospitalier Universitaire Vaudois (CH), Massachusetts General Hospital (US), St. Luke's Children's Hospital (US), Institute for Exercise and Environmental Medicine (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Cardiovascular Effects of Exercise
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon